Meta Data Center Triggers Environmental Scrutiny
A massive Meta data center, dubbed "Project Cosmo," currently under construction in Wyoming, has unexpectedly become the focal point of a public health and environmental investigation. Officials have traced a rare bacterium, Cupriavidus gilardii, to wastewater discharged from the site, triggering new wastewater regulations and intensifying scrutiny on the environmental footprint of the rapidly expanding data center industry across the United States.
The Discovery of Cupriavidus gilardii
The Cheyenne Board of Public Utilities (BOPU) first detected Cupriavidus gilardii during routine sampling of its reclaimed water irrigation system in February. After several months of testing, investigators concluded that the source was wastewater linked to Meta's 715,000-square-foot facility in southeast Wyoming, being built by contractor Fortis Construction. Authorities confirmed that the contamination was found in reclaimed wastewater used for irrigation and did not affect the city's drinking water system.
Following the investigation, Cheyenne permanently revoked the project's permission to discharge wastewater into municipal treatment facilities. The city has also introduced stricter regulations governing wastewater generated during data center construction, particularly from closed-loop cooling and fill-and-flush systems that circulate purified water to clean newly installed pipes. Meta stated it has directed its contractor to fully cooperate with local authorities and reiterated that independent environmental testing commissioned by the contractor did not detect the bacterium, confirming public drinking water remained unaffected.
Understanding Cupriavidus gilardii
Cupriavidus gilardii is a naturally occurring bacterium commonly found in soil and environmental water sources. It is classified as an "opportunistic pathogen," meaning it rarely causes illness in healthy individuals but can pose a significant threat to those with weakened immune systems. Despite infections being extremely uncommon, medical experts consider it clinically significant due to its potential to cause severe infections in vulnerable patients and its resistance to several commonly used antibiotics.
Who is Most at Risk?
Most healthy individuals are unlikely to fall ill after exposure to Cupriavidus gilardii. The highest risk is for people with compromised immune systems, including cancer patients, organ transplant recipients, elderly individuals, and patients undergoing invasive medical procedures such as catheter or pacemaker implantation. In these vulnerable populations, the bacterium has been linked to serious bloodstream infections, pneumonia, septic shock, cholecystitis, and, in rare cases, fatal sepsis. Typical symptoms include persistent high fever, breathing difficulties, elevated white blood cell counts, and increased inflammatory markers such such as C-reactive protein (CRP).
The Challenge of Antibiotic Resistance
One of the primary concerns surrounding C. gilardii is its notable resistance to antibiotics. The bacterium carries intrinsic antimicrobial resistance genes, making it naturally resistant to carbapenems, including meropenem and imipenem, which are often considered last-resort antibiotics. It also exhibits resistance to aminoglycosides and has, in some cases, shown resistance to newer drugs like cefiderocol. Effective treatment therefore necessitates careful laboratory testing, as some strains may respond to antibiotics such as cefepime, ciprofloxacin, minocycline, or ceftazidime-avibactam. Adding to the diagnostic challenge, standard laboratory tests may misidentify the organism, often requiring advanced molecular techniques like 16S rRNA gene sequencing or metagenomic next-generation sequencing (mNGS) for accurate identification.
Rarity of Human Infections
Documented human infections with Cupriavidus gilardii remain exceptionally uncommon, with only a handful of confirmed cases reported worldwide. A March 2026 study in the International Journal of Infectious Diseases detailed a patient who succumbed to septic shock after contracting the bacterium during a cord blood transplantation procedure. Earlier reports have also documented isolated fatal cases, including that of a 12-year-old American girl who developed sepsis while traveling in Europe. Despite these severe cases, experts continue to classify the bacterium as a low-virulence environmental organism that poses minimal threat to the general population.
Broader Implications for Data Centers
Beyond the immediate public health concerns, the Wyoming incident underscores the increasing criticism facing data centers over their growing demand for water and electricity. Modern, AI-ready data centers require enormous volumes of water for cooling servers, with some facilities consuming as much as 300,000 gallons daily—an amount roughly equivalent to the water needs of about 1,000 households. Although the bacterium itself did not enter Cheyenne's drinking water, the incident has highlighted how large-scale technology infrastructure projects can create unexpected environmental challenges, prompting regulators to tighten oversight of wastewater disposal as AI-driven data center construction accelerates across the United States.